ClearTau: A new tool for studying neurodegenerative diseases

EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer’s disease and other neurodegenerative diseases. The breakthrough may speed up the development of diagnostics and targeted therapies for Tau-related disorders.

Leave A Comment

Your email address will not be published. Required fields are marked *